Replies to post #193386 on Biotech Values

[DewDiligence]

I can’t get past OCAT’s balance sheet, and hence I haven’t seriously looked at the science.

[north40000]

Not Dew, but we have had many dialogues re OCAT here, both public and private.

Recent Lanza talk:

http://ih.advfn.com/p.php?pid=nmona&article=66802987

video and transcript available on OCAT board and website. Same for Wotton's presentation more recently.

We have a sizable investment in OCAT. Pivotal phase II/III scheduled to start shortly in Stargaardt's macular dystrophy and phase II in dry AMD shortly thereafter.